BC-23
BC-23 (NSC 45382) is a proteasome inhibitor that selectively targets the chymotrypsin-like (CT-L) activity. It is utilized in cancer research, including studies on leukemia, lymphoma, and solid tumors, with both in vitro and in vivo experiments demonstrating its antitumor potential.
Product Specifications
CAS Number
6298-15-3
Field of Research
Protein Biochemistry
Purity
99.99% (May vary between batches)
Smiles
O=C1C=2C (C (=O) C (Cl) =C1NC3=CC=C (S (NC4=CC=CC=N4) (=O) =O) C=C3) =CC=CC2
Molecular Formula
C21H14ClN3O4S
Molecular Weight
439.87
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-EP007960HU-01 10 µg
Recombinant Human Acyl-CoA 6-desaturase (FADS2), partial
Sign In for Pricing
View Details CSB-EP007960HU-02 50 µg
Recombinant Human Acyl-CoA 6-desaturase (FADS2), partial
Sign In for Pricing
View Details